flubendazole has been researched along with albendazole sulfoxide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cvilink, V; Ketola, RA; Kostiainen, R; Lamka, J; Skálová, L; Szotáková, B | 1 |
| Čáňová, K; Hanušová, V; Knoppová, K; Králová, V; Skálová, L; Staňková, P | 1 |
| Dimunová, D; Lamka, J; Matoušková, P; Nguyen, LT; Sečkařová, A; Skálová, L; Stuchlíková, LR; Szotáková, B; Várady, M; Vokřál, I | 1 |
3 other study(ies) available for flubendazole and albendazole sulfoxide
| Article | Year |
|---|---|
LC-MS-MS identification of albendazole and flubendazole metabolites formed ex vivo by Haemonchus contortus.
Topics: Albendazole; Animals; Anthelmintics; Biotransformation; Chromatography, Liquid; Haemonchus; Mass Spectrometry; Mebendazole; Oxidation-Reduction | 2008 |
Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines.
Topics: Adenocarcinoma; Albendazole; Anthelmintics; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; G2 Phase; Humans; Inhibitory Concentration 50; Intestinal Neoplasms; Mebendazole; Microtubules; Paclitaxel; Protein Stability; Tubulin Modulators | 2013 |
Metabolism of albendazole, ricobendazole and flubendazole in Haemonchus contortus adults: Sex differences, resistance-related differences and the identification of new metabolites.
Topics: Albendazole; Animals; Anthelmintics; Biochemical Phenomena; Biotransformation; Drug Resistance; Female; Haemonchiasis; Haemonchus; Male; Mebendazole; Sex Factors; Sheep; Sheep Diseases; Tandem Mass Spectrometry | 2018 |